InSitu Biologics, Inc.

InSitu Biologics is an emerging biotech company focusing on development of INSB200, a non-opiate painkiller.

Add To Watchlist
General Information
Company Name
InSitu Biologics, Inc.
Founded Year
2014
Location (Offices)
Oakdale, United States +1
Founders / Decision Makers
Kevin Barrett, MBA Barrett - Chief Operating Officer Mark Ereth - Chief Medical Officer Kevin Bassett, MBA Bassett - President and CEO Bill Taylor - Chief Science Officer, Cofounder
Number of Employees
13
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Series Unknown
Social Media

InSitu Biologics, Inc. - Company Profile

InSitu Biologics, Inc.

InSitu Biologics, Inc. is an emerging biotech company with a focus on developing INSB200, a non-opiate painkiller. Founded in 2014 and headquartered in the United States, the company is dedicated to creating a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. Their disruptive technology is positioned to address unmet needs in the pain management and drug delivery markets.

The company recently received a significant boost with a $4.97M Venture Round investment on 24 February 2021. This investment is a testament to the potential and promise that InSitu Biologics holds in the biotechnology and healthcare industries.

With its innovative approach to addressing pain management and drug delivery, InSitu Biologics is poised to make significant strides in these sectors, potentially offering groundbreaking solutions to real-world challenges.

Taxonomy: biotech, drug development, pain management, drug delivery, localized treatment, disruptive technology, INSB200, non-opiate painkiller, prolonged release, cancer treatment, infection treatment, emerging company, startup, investor potential

Funding Rounds & Investors of InSitu Biologics, Inc. (2)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round $4.97M - 24 Feb 2021
Venture Round $2.00M 1
Manhattan Street Fund, investor in InSitu Biologics, Inc.'s Venture Round round
04 Dec 2018

Latest News of InSitu Biologics, Inc.

View All

No recent news or press coverage available for InSitu Biologics, Inc..

Similar Companies to InSitu Biologics, Inc.

View All
Leadopharma - Similar company to InSitu Biologics, Inc.
Leadopharma Pioneering the future of pain, epilepsy, depression, and neurodegenerative treatment through innovative drug synthesis and advanced pharmacology research.
Yannuo Pharmaceutical - Similar company to InSitu Biologics, Inc.
Yannuo Pharmaceutical Pioneering advanced therapies in oncology, contrast agents, and anesthesia through innovative drug delivery platforms.
The Control Center by Vitality Healthtech - Similar company to InSitu Biologics, Inc.
The Control Center by Vitality Healthtech Clinically-proven methods to reduce pain and opioid dependence.
Axxia Pharmaceuticals - Similar company to InSitu Biologics, Inc.
Axxia Pharmaceuticals Innovative polymeric implants for precise, long-term pain relief therapy.
Advanced Catheter Therapies, Inc. - Similar company to InSitu Biologics, Inc.
Advanced Catheter Therapies, Inc.
Circle Decoration Circle Decoration

Want to dive deeper into InSitu Biologics, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now